![Nikos Iatropoulos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nikos Iatropoulos
Directeur/Membre du Conseil chez Linnaeus Therapeutics, Inc.
Profil
Nikos Iatropoulos is currently a director at three different companies: Linnaeus Therapeutics, Inc., MixComm, Inc., and Leukovet.
Postes actifs de Nikos Iatropoulos
Sociétés | Poste | Début |
---|---|---|
Linnaeus Therapeutics, Inc.
![]() Linnaeus Therapeutics, Inc. BiotechnologyHealth Technology Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ. | Directeur/Membre du Conseil | - |
Leukovet
![]() Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Directeur/Membre du Conseil | - |
MixComm, Inc.
![]() MixComm, Inc. SemiconductorsElectronic Technology MixComm, Inc. manufactures semiconductors for transformative wireless solutions. The firm is a fabless semiconductor company developing transformative solutions for emerging wireless applications and markets. The company was founded by Harish Krishnaswamy and Frank Lane in 2017 and is headquartered in Chatham, NJ. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Linnaeus Therapeutics, Inc.
![]() Linnaeus Therapeutics, Inc. BiotechnologyHealth Technology Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ. | Health Technology |
Leukovet
![]() Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
MixComm, Inc.
![]() MixComm, Inc. SemiconductorsElectronic Technology MixComm, Inc. manufactures semiconductors for transformative wireless solutions. The firm is a fabless semiconductor company developing transformative solutions for emerging wireless applications and markets. The company was founded by Harish Krishnaswamy and Frank Lane in 2017 and is headquartered in Chatham, NJ. | Electronic Technology |